期刊文献+

Visfatin、IL-6、TNF-α与2型糖尿病的相关研究 被引量:9

The Study of IL-6,TNF-α and Visfatin in Type 2 Diabetes Mellitus
原文传递
导出
摘要 目的:探讨血浆visfatin、IL-6、TNF-α与2型糖尿病的关系。方法:2型糖尿病患者60例,正常对照组30例。根据体重指数分为肥胖组和非肥胖组。检测空腹血浆胰岛素、糖化血红蛋白、血糖、血脂、血压、visfatin、TNF-α、白介素-6等。计算体重指数、腰臀比值及稳态模型胰岛素抵抗指数(HOMA-IR)。结果:2型糖尿病组血浆visfatin、IL-6、TNF-α水平显著高于正常对照组(P<0.05);2型糖尿病组与正常肥胖组比较,糖尿病非肥胖组visfatin(301.60±58.07)明显升高,糖尿病肥胖组visfatin(336.68±37.61)、TNF-α(3.58±1.10)明显升高(P<0.05)。多元线性相关分析表明,在肥胖的2型糖尿病患者中血浆TNF-α与糖化血红蛋白显著正相关,血浆IL-6与血糖(FPG)显著正相关,血浆visfatin与腰臀比值(WHR)显著正相关(P<0.05)。结论:visfatin、IL-6、TNF-α的变化可能对2型糖尿病的发生、发展具有一定的作用。 Objective: To investigate the relationship among plasma visfatin,IL-6,TNF-α with type 2 diabetes mellitus(T2DM).Methods: 60 T2DM patients were selected as T2DM group and 30 healthy subjects as control group.According to body mass index(BMI) they were divided into two groups: obese group and non-obese group.Visfatin,IL-6,TNF-α,free insulin,HbA1c,free glucose,blood pressure,lipids were measured and the waist-to-hip ratio(WHR),BMI,homeostasis model assessment of insulin r esistance(HOMA-IR) were calculated.Results: Visfatin,IL-6 and TNF-α level was significantly higher in T2DM group than that in control group(P0.05);Visfatin(301.60±58.07)level was significantly higher in non-obese group of T2DM group than that in obese group of con-trols.Visfatin(336.68±37.61)and TNF-α(3.58±1.10)level was significantly higher in obese group of T2DM group than that in obese group of controls;The multiple logistic regression anlysis showed that,the TNF-α to glycosylated hemoglobin,the IL-6 to blood sugar,the visfatin levels was positively related to waist-hip ratio(WHR) in obese T2DM group(P0.05).Conclusions: The change of plasma IL-6,TNF-α and visfatin level may play a role in the pathogenesis and develonpment of Type 2 Diabetes Mellitus.
出处 《现代生物医学进展》 CAS 2011年第24期4908-4911,共4页 Progress in Modern Biomedicine
基金 哈尔滨市科技局科研基金资助项目(2009RFQQS039)
关键词 VISFATIN IL-6 TNF-Α 糖尿病 2型 Visfatin IL-6 TNF-α Diabetes mellitus 2 type
  • 相关文献

参考文献23

  • 1Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein se- creted by visceral fat that mimics the effects of insulin [J].Science, 2005,307(5708) : 426-430.
  • 2Festa A D, Agostino R Jr, M ykkanen L, et al. Relative contribution of in sulin and its precursors to fibrinogen and PA I- 1 in a large popula- tion with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study ( IRAS ) [ J]. Arterioscler Thromb Vasc B io, 11999. 19: 562- 568.
  • 3Leinonen E, Hu rt- camejo E, W ik lund O, et al. Insuin resistance and adiposity correlate with acute- phase reaction and soluble cell adhe- sion molecules in type 2 diabetes [J]. Atheroscleros is, 2003, 166:387- 394.
  • 4Forsythe L,Wallace J,Livingstone M.Obesity and inflammation:the ef- fects of weight loss[J].Nutr Res Rev,2008,21 (2): 117-133.
  • 5Espesito K, NaPPo F, Marfella R, et al. Inflammation cytokine Con- centrations are aeutely inereased by hyperglycemia in human:role of oxidative stress[J]. Cireulation, 2002,106:2067-2072.
  • 6Winkler G, Salamon F, Harmos G, et al. Eleavated serum tumor necro- sis factor-alpha concentrations and bioactivity in Type 2 diabetics and patients with android type obesity[J].Diabetes Res Clin Pract,1998, 42 (3):169-174.
  • 7Haider DG, Schindler K, Schaller G, et al. Increased plasma visfatin concentrations inmorbidly obese subjects are reduced after gastric banding [J].JClin EndocrinolMetab, 2006,91 (4): 1 578-581.
  • 8Varma V, Yao-Borengasser A, Rasouli N, et al.Human visfatin expression: relations hip to insulin sensitivity, intramyocellular lipids, and inflammation[J].JClin Endocrinol Metab,2007,92(2): 666-672.
  • 9Szamatowicz J, Kumicki M, Telejko B, et al. Serum visfatin concen- tration is elevated in pregnantwomen irrespectively of the presence of gestational diabetes [J]. Ginekol Pol, 2009,80(1): 14-18.
  • 10Chen MP, Chung FM, Chang DM, et al. Elevated plasma level of vis- fatin/pre-B cell colony-enhancing factor in patients with type 2 dia- betes mellitus [J]. J Clin Endoerinol Metab,2006,91(1):295-299.

二级参考文献11

  • 1Luk T, Malam Z, Marshall JC. Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity [ J]. J Leukoc Biol. 2008, 83(4): 804-816.
  • 2Revollo JR, Korner A, MiUs KF, et al. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme[J]. Cell Metab, 2007, 6(5) : 363 -375.
  • 3Lopez-Bermejo A, Chlco-Julia B, Fernamdez-Balsells M, et al. Serum visfatin increases witb progressive beta-cell deterioration[J]. Diabetes, 2006, 55( 12): 2871 -2875.
  • 4Bailey SD, Loredo-Osti JC, Lepage P, et al. Common polymorphisms in the promoter of the visfatin gene (PBEF1) influence plasma insulin levels in a French-Canadian population [ J ]. Diabetes, 2006, 55(10): 2896-2902.
  • 5Hu W, Xie J, Zhao J, et al. Involvement of bcl-2 family in apoptosis and signal pathways induced by cigarette smoke extract in the human airway smooth muscle cells[J]. DNA Cell Biol, 2008, 17( 12): 13 - 22.
  • 6Wang P, Xu TY, Guan YF, et al. Perivascular adipose tissuederived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide [ J]. Cardiovasc Res, 2009, 81 (2) : 370 -380.
  • 7Li Y, Zhang Y, Dorweiler B, et al. Extracellular Nampt promotes macrophage survival via a nonenzymatic interleukin-6/STAT3 signaling mechanism[ J]. J Biol Chem, 2008, 283 (50) : 34833 - 34843.
  • 8Rongvaux A, Galli M, Denanglaire S, et al. Nicotinamide phosphofibosyl transferase/pre-B cell colony-enhancing factor/visfatin is required for lymphocyte development and cellular resistance to genotoxic stress[J]. J Immunol, 2008, 181 (7) : 4685 -4695.
  • 9Yang H, Yang T, Baur JA,et al. Nutrient-sensitive mitochondrial NAD + levels dictate cell survival[J]. Cell, 2007, 130(6) : 1095 - 1107.
  • 10Lira SY, Davidson SM, Paramanathan AJ,et al. The novel adipocytokine visfatin exerts direct cardioprotective effects[ J], J Cell Mol Med, 2008, 12(4) : 1395 - 1403.

共引文献12

同被引文献88

  • 1郝新忠,陈隽,杨妤欣,刘云,郑瑞芝.2型糖尿病大鼠活化肺泡巨噬细胞CD14表达及TNF-α、IL-6分泌减少[J].中国糖尿病杂志,2006,14(1):52-55. 被引量:4
  • 2何岚,齐学林,高烨,樊新华,郭辉,冯潭溪.青少年血清瘦素水平与肥胖、血糖及胰岛素的关系[J].西安交通大学学报(医学版),2006,27(3):258-260. 被引量:9
  • 3孙涛 李向东 杨文东.2型糖尿病患者血清IL-6、hs-CRP及APN水平变化及其相关性.医学检验与临床,2009,20(1):10-13.
  • 4Koh K K, Park S M, Quon M J. Leptin and cardiovascu lar disease response to therapeutic intervention[J]. Circu lation, 2008,117 : 3238-3249.
  • 5Craig A, Lygate, Steffen Bohl, et al. Moderate elevation of intracellular creatine by targeting the creatine trans- porter protects mice from acute myocardial infarction[J]. Cardiovascular Research, 2012,96,466-475.
  • 6Hilzendeger A M, Morais,R L,Todiras M, et al. Leptin regulates ACE activity in mice[J]. J Mol Med, 2010,88 (9) :899-907.
  • 7Jeffrey P, Cardinale, Srinivas Sriramula. Angiotensin Ⅱ-Induced hypertension is modulated by nuclear factor- kB in the paraventricular nucleus [J]. Hpertention, 2012,59:113-121.
  • 8Yang WY,Lu JM,Weng JP,et al.Prevalence of diabetes among men and women in China[J].N Engl J Med,2010,362 (12):1090-1101.
  • 9Knowler WC,Barrett-Connor E,Fowler SE,et al.Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin[J].N Engl J Med,2002,346 (6):393-403.
  • 10Lindstrom J,Ilanne Parikka P,Peltonen M,et al.Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention:follow up of the Finnish Diabetes Prevention Study[J].Lancet,2006,368 (9548):1673-1679.

引证文献9

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部